Phase 1 of the CFP Weight Loss Protocol, known as Fat Loading, serves as the critical foundation for sustainable metabolic transformation. Rather than jumping straight into calorie restriction, this preparatory stage strategically increases healthy fat intake while introducing tirzepatide to recalibrate hunger hormones and prime the body for efficient fat burning.
This 14-day phase focuses on restoring leptin sensitivity, reducing systemic inflammation, and shifting mitochondrial function from sugar-burning to fat-oxidizing. By loading with quality fats and eliminating inflammatory triggers, participants prepare their physiology for the aggressive fat-loss window that follows.
Understanding the Science Behind Fat Loading
Traditional CICO approaches overlook how hormones dictate whether calories are stored or burned. During Phase 1, we target key players: GLP-1, GIP, and leptin. Tirzepatide, a dual GLP-1/GIP receptor agonist, mimics these incretin hormones to slow gastric emptying, stabilize blood glucose, and signal satiety to the brain.
Leptin sensitivity—the brain’s ability to register “I am full”—is often blunted by chronic inflammation and high-sugar diets. An anti-inflammatory protocol emphasizing nutrient-dense, lectin-free foods helps quiet this internal fire. Meanwhile, elevated C-reactive protein (CRP) levels, a marker of systemic inflammation, typically begin to decline as participants remove lectins from grains, legumes, and nightshades.
Mitochondrial efficiency also improves. By providing ample healthy fats and reducing oxidative stress, cells generate ATP with fewer reactive oxygen species. This cellular renewal sets the stage for higher basal metabolic rate (BMR) preservation throughout the journey.
The 30-Week Tirzepatide Reset Framework
The signature 30-week tirzepatide reset uses a single 60 mg box strategically cycled across three distinct phases. Phase 1 (Fat Loading) lasts approximately 14 days at a micro-dose, Phase 2 (Aggressive Loss) spans 40 days with slightly higher dosing, and the Maintenance Phase covers the final 28 days to stabilize results.
Subcutaneous injections are administered weekly, rotating sites between the abdomen, thigh, and upper arm to minimize irritation. The low-dose approach in Phase 1 prevents abrupt side effects while allowing the body to adapt to enhanced GLP-1 and GIP signaling. This gradual introduction supports improved insulin sensitivity, reflected in declining HOMA-IR scores.
Importantly, this isn’t lifelong dependency. The protocol aims for a true metabolic reset—retraining the body to utilize stored fat for fuel and naturally regulate appetite once the cycle concludes.
Nutritional Strategy: What to Eat During Fat Loading
Phase 1 prioritizes nutrient density over calorie counting. Participants consume 60-70% of calories from healthy fats including avocados, olive oil, coconut oil, fatty fish, and grass-fed meats. Moderate protein intake protects lean muscle mass, while carbohydrates stay below 50 grams daily from low-lectin, non-starchy vegetables.
Bok choy becomes a staple—its high vitamin K, C, and antioxidant content supports detoxification without triggering inflammation. Other approved foods include leafy greens, cruciferous vegetables, berries, and small amounts of macadamia nuts. This lectin-free framework reduces gut permeability and lowers CRP, creating an environment where fat cells can readily release stored energy.
Hydration and electrolytes receive special attention as the body adjusts to lower carbohydrates. Bone broth, mineral-rich salts, and magnesium supplementation help prevent common transition symptoms.
Expected Physiological Changes and Tracking Progress
During the first two weeks, many experience reduced hunger, stable energy, and initial water weight shifts. Body composition improves as inflammation decreases, even before significant scale movement. Ketone production begins modestly, signaling early fat adaptation.
Key metrics to monitor include fasting insulin, HOMA-IR, hs-CRP, and body composition via bioelectrical impedance or DEXA. Improvements in these markers often precede visible fat loss, confirming the protocol is addressing root causes rather than masking symptoms.
Sleep quality typically improves due to stabilized blood sugar, while mental clarity emerges as the brain adapts to using ketones. These non-scale victories reinforce that the metabolic reset is underway.
Transitioning Successfully into Phase 2
The ultimate goal of Phase 1 is seamless preparation for the 40-day Aggressive Loss phase. By restoring leptin sensitivity and mitochondrial efficiency, the body becomes primed to mobilize visceral and subcutaneous fat stores effectively.
Participants who fully commit to the anti-inflammatory, nutrient-dense framework report fewer cravings and more consistent energy when entering the stricter low-carb protocol of Phase 2. The hormonal recalibration achieved during fat loading makes subsequent calorie cycling feel natural rather than restrictive.
Successful completion of this phase establishes the foundation for lasting change. The CFP protocol demonstrates that sustainable weight management stems from repairing metabolic signaling—not perpetual restriction.
By understanding and honoring the body’s complex hormonal language during these initial 14 days, individuals position themselves for profound, maintainable transformation that extends far beyond the numbers on a scale.